Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)

PHASE2UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Aortic Valve Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin K2 (Menaquinone 7) + Vitamin D3

Vitamin K2 + Vitamin D3 arm will be compared with Vitamin D3 arm to slow of reverse the progression of the disease

Trial Locations (1)

Unknown

RECRUITING

Hopital Saint-George Ajaltoun, Beirut

All Listed Sponsors
collaborator

Omicron Pharmaceuticals

INDUSTRY

collaborator

Nattopharma ASA

INDUSTRY

lead

Hopital St. Georges, Ajaltoun

OTHER